期刊文献+

p185高表达人卵巢癌裸鼠模型的建立 被引量:2

Establishment of nude mice model of human ovarian carcinoma exhibiting high p185 expression
下载PDF
导出
摘要 目的建立高表达p185的人卵巢癌裸鼠模型。方法BALB/c裸鼠皮下接种高表达p185的人卵巢癌细胞株SKOV3,观察成瘤情况及移植瘤病理组织学特点,并用SP免疫组织化学法测定移植瘤的p185表达情况。结果12只裸鼠均荷瘤成功,病理组织学与免疫组化均证实移植瘤保持了原细胞系特征。结论高表达p185人卵巢癌裸鼠模型的成功建立为抗p185抗体药物的体内药效研究提供了理想的平台。 Objective To establish an animal model of human ovarian cancer overexpressing p185 in nude mice. Methods A human itvarian cancer cell line SKOV3 was administered suhcutaneously to trade mice, The tumor growth and histopathological features were observed, and p185 level in tumor cell surface was evaluated by SP immunohistochemistry. Results Twelve nude mice were successfully transplanted with the tumor. The features of the transplanted tumors were the same as the primary cell line in histopathological and immunohistochemical assays. Conclusion The animal model of human ovarian cancer overexpressing p185 is established successfully. It provides a useful tool for studying the effect of anti-p185 antibodies on tumor growth.
出处 《安徽医科大学学报》 CAS 北大核心 2005年第4期300-301,共2页 Acta Universitatis Medicinalis Anhui
基金 国家863计划(编号:2001AA5381)
关键词 卵巢肿瘤 小鼠 疾病模型 动物 ovarian neoplasms mice, nude disease models animal
  • 相关文献

参考文献3

二级参考文献11

  • 1Shen R Q,J National Cancer Institute,1994年,86期,91页
  • 2Press MF,Hung G,Godolphin W et al.Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in the immunohistochemical, studies of oncogene expression[].Cancer Research.1994
  • 3Harris LN,Liotcheva V,Broadwater G et al.Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy[].Journal of Clinical Oncology.2001
  • 4Pauletti G,Dandekar S,Rong H et al.Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer : adirect comparison of fluorescence in situ hybridization and immunohistochemistry[].Journal of Clinical Oncology.2000
  • 5Pegram MD,Lipton A,Hayes DF et al.Phase Ⅱstudy of receptor-enhanced chemosensitivity using recombinant humanized antip185 HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy[].Journal of Clinical Oncology.1998
  • 6Jacobs TW,Gown AM,Yaziji H et al.Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer[].Journal of Clinical Oncology.1999
  • 7Tsuda H,Hirohashi S,Shimosato A et al.Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma[].Cancer.1990
  • 8Roche PC,Ingle JN.Increased HER-2 with US food and Drug Administration approved antibody[].Journal of Clinical Oncology.1999
  • 9Cobleigh MA,Vogel CL,Tripathy D et al.Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy; for metastatic disease[].Journal of Clinical Oncology.1999
  • 10Ross JS,Fletcher JA.HER-2/neu (c-erbB-2) gene and protein in breast cancer[].American Journal of Clinical Pathology.1999

共引文献10

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部